Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Aurobindo’s CuraTeQ Withdraws European Biosimilars – But They Will Be Back
EMA Refiling Expected After Filgrastim And Pegfilgrastim Applications Withdrawn
CuraTeQ has withdrawn two biosimilar filings • Source: Shutterstock
More from Biosimilars
More from Products